Cargando…

Successful twin pregnancy in a 38-year-old woman with Pompe disease despite interruption of enzyme replacement therapy (ERT)

Detalles Bibliográficos
Autores principales:	Tiling, N, Bosanska, L, Gossing, G, Krieg, H, Krebs, A, Rosseau, S, Schütte, H, Irlbacher, K, Plöckinger, U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667056/ http://dx.doi.org/10.1186/1471-2474-14-S2-P8

Ejemplares similares

Pompe disease: the role of MRI
por: Fernández, C Pérez, et al.
Publicado: (2013)

Enzyme replacement therapy (ERT) in pompe disease
por: Fiumara, Agata
Publicado: (2014)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018)

Pregnancy in Pompe disease
por: Plöckinger, Ursula
Publicado: (2013)

Effect of enzyme replacement therapy (ERT) added to Home Mechanical Ventilation (HMV) in Adult Pompe disease
por: Sayeed, Nadia, et al.
Publicado: (2015)

Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent
por: Nayak, Sushrusha, et al.
Publicado: (2014)

CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
por: Berrier, Kathryn L., et al.
Publicado: (2015)

Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile-Onset Pompe Disease: A Familial History
por: Lecis, Marco, et al.
Publicado: (2023)

Positive Impact of Home ERT for Mucopolysaccharidoses and Pompe Disease: The Lesson Learnt from the COVID-19 Pandemic
por: Fiumara, Agata, et al.
Publicado: (2023)

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021)

L-alanine supplementation in Pompe disease (IOPD): a potential therapeutic implementation for patients on ERT? A case report
por: Rovelli, Valentina, et al.
Publicado: (2022)

Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease
por: Sun, Baodong, et al.
Publicado: (2014)

Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
por: Han, Sang-oh, et al.
Publicado: (2017)

Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
por: Han, Sang-oh, et al.
Publicado: (2019)

Illness Perception and Clinical Treatment Experiences in Patients with M. Maroteaux-Lamy (Mucopolysaccharidosis Type VI) and a Turkish Migration Background in Germany
por: Dilger, Hansjörg, et al.
Publicado: (2013)

Safety outcomes and patients’ preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond
por: Toscano, Antonio, et al.
Publicado: (2023)

Estrogen replacement therapy (ERT) in high-risk cancer patients.
por: Hutchinson-Williams, K. A., et al.
Publicado: (1991)

Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT
por: Banugaria, Suhrad G., et al.
Publicado: (2013)

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease
por: Kazi, Zoheb B., et al.
Publicado: (2018)

Hackertámadás érte a svájci részecskegyorsító rendszerét
Publicado: (2008)

Rekord energiaszintet ért el az LHC
Publicado: (2009)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

Analysis of barley mutants ert-c.1 and ert-d.7 reveals two loci with additive effect on plant architecture
por: Lu, Qiongxian, et al.
Publicado: (2021)

Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice
por: Rossi, Martina, et al.
Publicado: (2023)

Correlation of simultaneous measurements of coronary, carotid and aortic distensibility and vessel wall ratio as evaluated by cardiovascular magnetic resonance in patients with type 2 diabetes mellitus
por: Winkel, David Jean, et al.
Publicado: (2013)

ERT impact on left ventricular mass in Fabry disease
por: Ortiz, Alberto
Publicado: (2019)

Extended Joint Sparsity Reconstruction for Spatial and Temporal ERT Imaging
por: Chen, Bo, et al.
Publicado: (2018)

Electrical resistivity tomography (ERT) data for clay mineral mapping
por: Arjwech, Rungroj, et al.
Publicado: (2020)

Astrocyte Specificity and Coverage of hGFAP-CreERT2 [Tg(GFAP-Cre/ERT2)13Kdmc] Mouse Line in Various Brain Regions
por: Park, Yongmin Mason, et al.
Publicado: (2018)

A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan
por: Fukuhara, Yasuyuki, et al.
Publicado: (2017)

Evaluation of muscle biopsy in late-onset GSDII patients before and after enzyme replacement therapy (ERT)
por: Violano, R, et al.
Publicado: (2013)

Comparison of Kindlin-2 deficiency-stimulated osteoarthritis-like lesions induced by Prg4(CreERT2) versus Aggrecan(CreERT2) transgene in mice
por: Yao, Qing, et al.
Publicado: (2023)

Pompes turbomoleculaires
por: Versolatto, B
Publicado: (1982)

Correlation between progression of left ventricular mass and atherosclerosis of carotid and coronary arteries in patients with type 2 diabetes mellitus under optimal medical treatment: a long-term CMR study
por: Xiong, Tingting, et al.
Publicado: (2013)

In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control
por: Felker, Anastasia, et al.
Publicado: (2016)

Application of electrical resistivity tomography (ERT) for rock mass quality evaluation
por: Hasan, Muhammad, et al.
Publicado: (2021)

Les pompes à chaleur
por: Veith, Heinz, et al.
Publicado: (1974)

Enzyme replacement therapy and fatigue in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

S2.1 Enzyme replacement therapy (ERT) in Glycogen Storage Disease Type II: the first treatment developed
por: Angelini, Corrado, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nkueu9iqu3lcnc6r0r2opjajcu